| Krebs Biochemicals & Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524518 |
NSE Symbol : KREBSBIO |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE268B01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -73.15 |
Market Cap(₹Cr) : 148.85 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 43.31 | 50.42 | 52.13 | 59.70 | 53.70 |
| Other Income | 0.71 | 0.45 | 0.62 | 1.16 | 0.62 |
| Stock Adjustments | -3.03 | -1.07 | -5.87 | 5.54 | -0.32 |
| Total Income | 40.99 | 49.80 | 46.88 | 66.40 | 54.00 |
| EXPENDITURE : | |||||
| Raw Materials | 2.53 | 5.52 | 19.81 | 46.18 | 25.62 |
| Power and Fuel Cost | 18.52 | 22.01 | 14.80 | 22.23 | 15.91 |
| Other Manufacturing Expenses | 12.59 | 9.75 | 7.17 | 9.64 | 10.48 |
| Selling and Administration Expenses | 5.24 | 4.50 | 4.57 | 6.11 | 3.39 |
| Miscellaneous Expenses | 0.13 | 0.11 | 0.17 | 0.11 | 0.24 |
| Employee Benefit Expenses | 16.30 | 16.17 | 15.54 | 14.96 | 15.30 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -14.32 | -8.27 | -15.16 | -32.84 | -16.95 |
| Interest | 5.91 | 4.69 | 2.97 | 5.39 | 6.28 |
| Gross Profit | -20.23 | -12.96 | -18.13 | -38.23 | -23.23 |
| Depreciation | 6.69 | 6.77 | 6.56 | 6.30 | 5.12 |
| Profit Before Tax | -26.92 | -19.73 | -24.69 | -44.53 | -28.35 |
| Current Tax | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 |
| Extraordinary Items | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -27.06 | -19.73 | -24.69 | -44.53 | -28.36 |
| Adjustment below Net Profit | -0.08 | -0.03 | 0.32 | -0.35 | 0.17 |
| Profit/Loss Balance carried down | -270.24 | -250.49 | -226.12 | -181.24 | -153.06 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -297.26 | -270.24 | -250.49 | -226.12 | -181.24 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | -67.83 | -55.29 | -46.13 | -34.83 | -23.91 |
| Book Value(Adj)-Unit Curr | -67.83 | -55.29 | -46.13 | -34.83 | -23.91 |